Shiori Uchiyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Shiori Uchiyama has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hiroshi Ochi
Food Ingredients & Technology Institute, R&D Division, Morinaga Milk Industry Co., Ltd., 5-1-83, Higashihara, Zama 252-8583, Japan
1 shared publication - Kazuo Umezawa
Department of Emergency and Critical Care, Tokai University School of Medicine, Isehara City, Kanagawa, Japan
1 shared publication - Maho Muramatsu
Graduate School of Science, Tokai University, 4-1-1 Kitakaname, Hiratsuka 259-1292, Japan
1 shared publication - Michihito Todaka
AIREX Inc., 4-1-1 Kitakaname, Hiratsuka 259-1292, Japan
1 shared publication - Ryo Sakiyama
Innovative Research Institute, R&D Division, Morinaga Milk Industry Co., Ltd., 5-1-83, Higashihara, Zama 252-8583, Japan
1 shared publication - Satomi Asai
Department of Laboratory Medicine, Tokai University School of Medicine, Isehara City, Kanagawa, Japan
1 shared publication
Latest Publications
- Open Access
- 20 March 2023
- Published by MDPI AG in Applied Sciences
- Vol. 13 (6) , 3930
Influence of Ingestion of Lactulose on γ-Lactones Emanating from Human Skin Surface
Lactulose is known to grow health-promoting bacteria, with an increase in the production of beneficial metabolites, such as lactic acid and short-chain fatty acids (SCFAs) in the colon. Ingestion of lactulose powder at a food dosage level is known to reduce the dermal emanation of ammonia, a typical human skin gas which potentially affects body odour. However, no study has reported the effect of lactulose on human skin gases other than ammonia. In this study, the influence of lactulose ingestion on the dermal emissions of γ-lactones, volatile cyclic esters with sweet smells, was investigated in healthy subjects. Healthy participants ingested the lactulose powder with a food dosage of 4 g d−1 once a day for 2 weeks. γ-lactones emanating from the skin surface were collected from each participant’s forearm by using a passive flux sampler, and six kinds of γ-lactones, namely, γ-hexalactone (C6), γ-heptalactone (C7), γ-octalactone (C8), γ-nonalactone (C9), γ-decalactone (C10), and γ-undecalactone (C11), were determined by gas chromatography–mass spectrometry. Quantification of bifidobacteria in faeces collected before and after ingestion of lactulose for 2 weeks was carried out by using real-time PCR. The results showed a significant increase in the dermal emission fluxes of sweet-smelling C10 and C11 lactones as the number of bifidobacteria increased in the faeces, presumably mediated by SCFAs produced in the colon.
- 20 March 2023
- Published by MDPI AG in Applied Sciences
- Vol. 13 (6) , 3930
Open AccessInfluence of Ingestion of Lactulose on γ-Lactones Emanating from Human Skin Surface
Lactulose is known to grow health-promoting bacteria, with an increase in the production of beneficial metabolites, such as lactic acid and short-chain fatty acids (SCFAs) in the colon. Ingestion of lactulose powder at a food dosage level is known to reduce the dermal emanation of ammonia, a typical human skin gas which potentially affects body odour. However, no study has reported the effect of lactulose on human skin gases other than ammonia. In this study, the influence of lactulose ingestion on the dermal emissions of γ-lactones, volatile cyclic esters with sweet smells, was investigated in healthy subjects. Healthy participants ingested the lactulose powder with a food dosage of 4 g d−1 once a day for 2 weeks. γ-lactones emanating from the skin surface were collected from each participant’s forearm by using a passive flux sampler, and six kinds of γ-lactones, namely, γ-hexalactone (C6), γ-heptalactone (C7), γ-octalactone (C8), γ-nonalactone (C9), γ-decalactone (C10), and γ-undecalactone (C11), were determined by gas chromatography–mass spectrometry. Quantification of bifidobacteria in faeces collected before and after ingestion of lactulose for 2 weeks was carried out by using real-time PCR. The results showed a significant increase in the dermal emission fluxes of sweet-smelling C10 and C11 lactones as the number of bifidobacteria increased in the faeces, presumably mediated by SCFAs produced in the colon.